Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

L. E. M. Oosten, M. E. D. Chamuleau, F. W. Thielen, L. C. de Wreede, C. Siemes, J. K. Doorduijn, O. S. Smeekes, M. J. Kersten, L. Hardi, J. W. Baars, A. M. P. Demandt, W. B. C. Stevens, M. Nijland, G. W. van Imhoff, R. Brouwer, C. A. Uyl-de Groot, P. M. Kluin, D. de Jong, H. Veelken

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)255-266
Number of pages12
JournalAnnals of Hematology
Volume97
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • Burkitt lymphoma
  • Drugtherapy
  • Survival
  • Cost nalysis
  • B-CELL LYMPHOMA
  • ALLOGENEIC TRANSPLANTATION
  • RESPONSE CRITERIA
  • CODOX-M/IVAC
  • LEUKEMIA
  • RITUXIMAB
  • COSTS
  • MULTICENTER
  • NETHERLANDS
  • PROTOCOLS

Cite this

Oosten, L. E. M., Chamuleau, M. E. D., Thielen, F. W., de Wreede, L. C., Siemes, C., Doorduijn, J. K., Smeekes, O. S., Kersten, M. J., Hardi, L., Baars, J. W., Demandt, A. M. P., Stevens, W. B. C., Nijland, M., van Imhoff, G. W., Brouwer, R., Uyl-de Groot, C. A., Kluin, P. M., de Jong, D., & Veelken, H. (2018). Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. Annals of Hematology, 97(2), 255-266. https://doi.org/10.1007/s00277-017-3167-7